Is second 131 I treatment necessary for differentiated thyroid cancer patients and who could not benefit from it? A real-world retrospective study in China
The efficacy of a second radioactive iodine-131 ( I) treatment in patients with differentiated thyroid cancer (DTC) who did not achieve an excellent response (ER) following initial I therapy remains controversy and the population that would derive limited benefit from it is currently unclear. The ai...
Gespeichert in:
| Veröffentlicht in: | Annals of nuclear medicine 2024-09 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!